share_log

HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $46 Price Target

Benzinga ·  Feb 28 12:50

HC Wainwright & Co. analyst Andrew Fein reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Buy and maintains $46 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment